David Martin
Dermatology · Anderson, INNPI 1952309510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 29.3% of the total. Reporting peaked in 2022 at $1,012 and has fallen 59.5% since, to $410 in 2023. That places this record below the midpoint for dermatology clinicians in IN, where the typical reported total is $3,818.
Across 220 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$623
- Sun Pharmaceutical Industries Inc.$385
- UCB, Inc.$355
- Incyte Corporation$167
- Genentech USA, Inc.$138
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,818100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,119 |
| Amgen | 34 | $623 |
| Sun Pharmaceutical Industries Inc. | 23 | $385 |
| UCB, Inc. | 20 | $355 |
| Incyte Corporation | 7 | $167 |
| Genentech USA, Inc. | 8 | $138 |
| E.r. Squibb & Sons, L.L.C. | 8 | $134 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $127 |
| LEO Pharma Inc. | 6 | $114 |
| Sanofi | 5 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Johnson & Johnson | 5 | $78 |
| Novartis | 4 | $76 |
| Bristol Myers Squibb | 3 | $76 |
| Pfizer | 4 | $62 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Almirall LLC | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
| Galderma Laboratories, L.p. | 1 | $12 |
| DUSA Pharmaceuticals, Inc. | 1 | $12 |
| Merck | 1 | $11 |
| Mayne Pharma Commercial LLC | 1 | $11 |
| Prugen, Inc. Pharmaceuticals | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$102
How this compares
$3,818 in reported general payments places this provider in the 45th percentile of 202 dermatology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 31 | $150,689 |
| Halobetasol Propionate | 22 | $1,094 |
| Clobetasol Propionate | 32 | $500 |
| Hydroxyzine Hcl | 18 | $497 |
| Fluocinonide | 14 | $454 |
| Ketoconazole | 40 | $373 |
| Triamcinolone Acetonide | 15 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $623 | $150,68931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 202 dermatology providers in Indiana.
Other dermatology in Anderson
- Minati SwoffordAnderson$9K
- Scott GuenthnerPlainfield$1.6M
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
- Priya YoungIndianapolis$492K
- Jeffrey SassmannshausenFort Wayne$489K
- Nikolajs PerdueIndianapolis$302K
- Michael SheehanColumbus$297K
- Alfred KnableNew Albany$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.